| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President and CEO | President and CEO
1 company
Brian Russell Wong is President and CEO at RAPT. Brian Russell Wong's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider.
Brian Russell Wong has 13 Form 4 filings on record from October 2019 to March 2026, all as President and CEO at RAPT Therapeutics (RAPT), 2019–2026.
The 36 reported transactions were 16 dispositions back to the company, 14 option or other derivative awards, 2 open-market purchases and 1 tender, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 2 purchases worth about $360K and 1 sale worth about $801K.
The largest open-market purchase was 25,000 shares of RAPT at an average $12.00 on November 4, 2019, about $300K.
The only open-market sale was 20,000 shares of RAPT at an average $40.05 on October 12, 2020, about $801K.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 12, 2020 | RAPT Rapt Therapeutics, Inc. | President and CEO | Sell | 20,000 | $40.05 | $801,040.00 | -5.6% | |
| Sep 23, 2020 | RAPT Rapt Therapeutics, Inc. | President and CEO | Buy | 2,000 | $30.06 | $60,120.00 | +0.6% | |
| Nov 4, 2019 | RAPT Rapt Therapeutics, Inc. | President and CEO | Buy | 25,000 | $12.00 | $300,000.00 | +25.0% |